title: Giving away HIV drugs is not as easy as it seems.
abstract: When officials with Boehringer ingelheim announced in July 2000 that the company would make its HIV antiretroviral drug nevirapine (Viramune) available to any pregnant women in sub-Saharan Africa who need it for the prevention of mother-to-child transmission of HIV, they thought their biggest problem would be to meet the flood of demand. They were wrong. Why has demand been so low?
mesh_terms: D017954:Africa South of the Sahara / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D004345:Drug Industry; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000635:transmission; D015528:HIV Seroprevalence; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents